// App-Quantinova.ai

SAT0313 : CORRELATION BETWEEN PROGRESSION OF SKIN FIBROSIS AND PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH SSC-ILD: DATA FROM THE SENSCIS TRIAL

Researchers

Presenter

  • O. Distler

Principal Investigators

  • K. Highland

  • A. M. Hoffmann-Vold

  • O. Kowal-Bielecka

  • U. Walker

  • F. Del Galdo

  • M. Vonk

  • L. Hummers

  • E. Erhardt

  • M. Quaresma

  • M. Alves

  • V. Smith

Medical Centers

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • Cleveland Clinic, Cleveland, United States,

  • Department of Oncology, Oslo University Hospital, Oslo, Norway

  • Department of Endocrinology and Diabetes with Internal Medicine, Medical University in Bialystok, Bialystok, Poland

  • Department of Gynecological Oncology, University Hospital Basel, Basel, Switzerland

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, United States

  • mainanalytics GmbH, Sulzbach, Germany

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium; Dept. of Internal Medicine, Ghent University, Ghent, Belgium, Ghent, Belgium

Locations

  • Switzerland

  • United States

  • Norway

  • Poland

  • United Kingdom

  • Netherlands

  • Germany

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Genetic Disorder

Disease

  • Interstitial lung disease

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Acetelion

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved